Runben Biotechnology Co Ltd
SSE:603193

Watchlist Manager
Runben Biotechnology Co Ltd Logo
Runben Biotechnology Co Ltd
SSE:603193
Watchlist
Price: 24.67 CNY 1.77%
Market Cap: 10B CNY

Profitability Summary

Runben Biotechnology Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Runben Biotechnology Co Ltd

Revenue
1.5B CNY
Cost of Revenue
-651.1m CNY
Gross Profit
867m CNY
Operating Expenses
-533.1m CNY
Operating Income
334m CNY
Other Expenses
-28.6m CNY
Net Income
305.3m CNY

Margins Comparison
Runben Biotechnology Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Runben Biotechnology Co Ltd
SSE:603193
10B CNY
57%
22%
20%
US
Kenvue Inc
NYSE:KVUE
33B USD
59%
18%
10%
BR
Natura &Co Holding SA
OTC:NTCOY
7.7B USD
65%
4%
-30%
KR
APR Co Ltd
KRX:278470
9.3T KRW
75%
20%
17%
CN
Mao Geping Cosmetics Co Ltd
HKEX:1318
42.9B HKD
84%
31%
24%
KY
Herbalife Ltd
XMUN:HOO
3.9B EUR
78%
13%
6%
IL
Oddity Tech Ltd
NASDAQ:ODD
2.4B USD
73%
16%
14%
KR
d'Alba Global Co Ltd
KRX:483650
1.8T KRW
76%
19%
5%
ID
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
16.2T IDR
59%
37%
30%
CN
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
6.6B CNY
49%
10%
10%
IN
Honasa Consumer Ltd
NSE:HONASA
83.6B INR
71%
5%
6%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Runben Biotechnology Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Runben Biotechnology Co Ltd
SSE:603193
10B CNY
14%
14%
16%
14%
US
Kenvue Inc
NYSE:KVUE
33B USD
14%
5%
13%
9%
BR
Natura &Co Holding SA
OTC:NTCOY
7.7B USD
-49%
-24%
5%
-19%
KR
APR Co Ltd
KRX:278470
9.3T KRW
56%
34%
54%
50%
CN
Mao Geping Cosmetics Co Ltd
HKEX:1318
42.9B HKD
41%
31%
54%
76%
KY
Herbalife Ltd
XMUN:HOO
3.9B EUR
-41%
12%
41%
32%
IL
Oddity Tech Ltd
NASDAQ:ODD
2.4B USD
30%
14%
17%
32%
KR
d'Alba Global Co Ltd
KRX:483650
1.8T KRW N/A N/A N/A N/A
ID
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
16.2T IDR
34%
32%
42%
41%
CN
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
6.6B CNY
13%
9%
12%
24%
IN
Honasa Consumer Ltd
NSE:HONASA
83.6B INR
11%
7%
8%
9%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less